Monitoring of CD8(+) T-cell Activity in mTOR Inhibitor-treated Cancer Patients for Successful Immunotherapy
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference9 articles.
1. Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients;Martínez-Mier;Arch Med Res,2006
2. Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47);Slingluff;Clin Cancer Res,2013
3. Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08);Templeton;Eur Urol,2013
4. mTOR regulates memory CD8 T-cell differentiation;Araki;Nature,2009
5. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T-cell responses for tumor immunity;Li;J Immunol,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway;Bioengineered;2022-04-01
2. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved;Archives of Biochemistry and Biophysics;2020-08
3. Obesity and COVID‐19: The mTOR pathway as a possible culprit;Obesity Reviews;2020-06-23
4. Streptomyces, shared microbiome member of soil and gut, as ‘old friends’ against colon cancer;FEMS Microbiology Ecology;2018-06-14
5. Drug discovery targeting the mTOR pathway;Clinical Science;2018-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3